Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes-Reference-Cited by-同舟云学术

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Published:2010-05 Issue:2 Volume:95 Page:178-184
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Fernandes Annemarie T.,Shen Jason,Finlay Jarod,Mitra Nandita,Evans Tracey,Stevenson James,Langer Corey,Lin Lilie,Hahn Stephen,Glatstein Eli,Rengan Ramesh

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference29 articles.

1. Lung Cancer. 10 June 2009. Centers for Disease Control and Prevention. ; 6 July 2009.

2. Perez and Brady’s principles and practice of radiation oncology;Halperin,2008

3. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients;Le Chevalier;J Natl Cancer Inst,1991

4. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee;Saunders;Lancet,1997

5. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and Management of Cardiotoxicity Secondary to Thoracic Radiation;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024

2. Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival;Frontiers in Oncology;2023-10-10

3. IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center;Frontiers in Oncology;2023-09-20

4. Recommendations for diagnosis and treatment of patients with lung cancer;ONKOLOGIJA;2023

5. Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer;Cancers;2023-01-21